ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids

NCT05629702 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
Brain Tumor
Cannabis
Brain Tumor, Recurrent

Interventions

DRUG: Nabiximols
DRUG: Temozolomide
DRUG: Nabiximols-matched placebo

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]
[object Object]